CFTR and cystic fibrosis: In patients with CF, certain classes of cystic fibrosis transmembrane conductance regulator (CFTR) mutations (I and II) are associated with more severe disease status, and reduced peakV ̇O2 is also associated with these classes of mutations [21], showing a link between genotype and a biomarker (peakV ̇O2).